Automated CPR Devices Market Size (2025 –2030)

The Automated CPR Devices Market was valued at USD 135.6 billion and is projected to reach a market size of USD 240.7 billion by the end of 2030. Over the forecast period of 2025-2030, the market is projected to grow at a CAGR of 12.16%.

The market for automated CPR devices is witnessing strong growth, driven by innovations in emergency medical technology and the growing incidence of cardiovascular conditions across the world. Automated CPR devices like mechanical chest compressors are finding increasing adoption as they provide uniform and high-quality chest compressions during cardiac arrest, minimizing human error and enhancing patient survival rates. Such devices are particularly useful in the pre-hospital and hospital environments, where rapid and effective resuscitation is needed. As clinicians aim to enhance survival in sudden cardiac arrest, automated CPR devices provide a proven solution that assists both healthcare professionals and first responders. The market is also propelled by increasing recognition of the need for high-quality CPR and advanced equipment in emergency departments. Moreover, regulatory agencies are slowly implementing supportive guidelines, pushing innovation and the uptake of such life-saving technologies. The soaring need for technologically superior medical devices, combined with a growing proportion of older people, is anticipated to grow the market heavily through 2030. As the healthcare sector continues to focus on patient safety and efficient resuscitation techniques, the market for automated CPR devices is likely to experience tremendous growth over the next few years.

Key Market Insights:

• Automated CPR devices are increasingly being used in emergency medical services (EMS) because they are capable of delivering high-quality chest compressions without human error. Devices like the LUCAS device and AutoPulse are becoming regular equipment in ambulances and emergency departments, improving survival rates in cases of sudden cardiac arrest. Their capability to deliver uninterrupted, consistent compressions without the risk of fatigue is transforming pre-hospital and hospital care.
• Most automated CPR machines are integrating artificial intelligence (AI) to improve their capabilities, enabling real-time adjustment of compression depth and rate according to the patient's status. AI-powered devices also give feedback and performance monitoring, enhancing outcomes by guaranteeing strict adherence to guidelines. This technology is a significant improvement in the accuracy of life-saving interventions.
• Corporations are increasingly investing in research and development to optimize the performance and affordability of automated CPR devices. Technological innovations are aimed at minimizing device size for ease of portability and extending battery life for increased usage in remote or difficult environments. Some new models are being tested to enable such devices to be used in a broader array of healthcare facilities.
• In countries such as Asia-Pacific and Latin America, where cardiac disease incidence is increasing at a very high rate, there is an initiative to implement automated CPR devices in the health infrastructure. Governments and businesses are coming together to make these devices cost-effective and available in rural and underserved areas. This is an important move to enhance emergency response mechanisms in areas that lack easy access to trained medical personnel.
• Regulatory bodies like the FDA and the European Medicines Agency (EMA) have laid down more specific guidelines for the approval and usage of automated CPR devices. The regulations provide assurance that new devices undergo rigorous safety checks before being put on the market. Concurrently, international healthcare organizations are calling for revised CPR guidelines that promote the usage of these devices to provide improved results in cases of cardiac arrest.

Automated CPR Devices Market Drivers:

Growing Incidence of Cardiovascular Diseases is Driving the Market Growth

The increasing prevalence of cardiovascular diseases (CVDs), especially among aging populations, is a key growth driver for the automated CPR devices market. As per the World Health Organization (WHO), CVDs are the most common cause of death worldwide, with an estimated 17.9 million deaths in 2019 alone. The increasing incidence of heart-related conditions highlights the importance of effective and timely resuscitation solutions, which automated CPR devices can offer.

Enhanced Patient Survival and Outcomes

Automated CPR machines are demonstrated to enhance the quality of chest compressions, resulting in enhanced survival rates for cardiac arrest patients. Research has indicated that mechanical chest compression devices, such as the **LUCAS** and **AutoPulse**, provide more uniform compressions compared to manual CPR, with greater chances of return of spontaneous circulation (ROSC). The capacity of these devices to provide uninterrupted, high-quality CPR without fatigue is fueling their uptake in both pre-hospital and hospital environments.

Medical Device Technology Upgrades

The incorporation of cutting-edge technologies, including Artificial Intelligence (AI) and Machine Learning (ML), in self-administered CPR devices is enhancing their efficacy and popularity. These technologies provide real-time patient feedback and adaptability of compression depth, rate, and quality, ensuring maximal performance during the resuscitation process. As medical professionals seek greater precision and efficiency in interventions that save lives, the usage of these new-generation devices will significantly increase.

Automated CPR Devices Market Restraints and Challenges:

High Device and Maintenance Costs

The upfront cost of automated CPR devices, as well as the maintenance and training expenses, can be prohibitive, especially in resource-poor areas. These devices, particularly advanced ones such as the LUCAS 3 and AutoPulse, are costly and might not be within the reach of all healthcare systems. This high expense restricts universal use, particularly in developing nations or smaller healthcare facilities with tight budgets.

Training and Skill Requirements for Proper Use

Although automated CPR devices provide a more uniform type of resuscitation, proper training is needed for health professionals to use them adequately. Misuse or inappropriate settings may result in less-than-optimal outcomes for patients, and extensive training programs must be implemented to certify that EMS crews and hospital staff members are skilled. The recurrent requirement for training contributes to the total expense and logistical effort involved in the uptake of such devices in emergency contexts.

Compliance and Regulatory Challenges

The automated CPR devices industry is governed by strict regulation from agencies like the FDA and the European Medicines Agency (EMA), whose regulatory pace slows down the entry of new technology to the market. Devices are thoroughly tested and must adhere to high safety standards before they are approved, hence, the approval process is costly and time-consuming. Also, regional differences in regulation complicate distribution and market entry globally and thus slow the large-scale use of newer models.

Automated CPR Devices Market Opportunities:

The market for automated CPR devices has great future prospects based on a number of factors. With the growing global ageing population, there's a greater likelihood of cardiovascular diseases, which increases the demand for effective life-saving technology such as automated CPR devices. Furthermore, opportunities to improve device performance using AI and machine learning exist to make real-time, data-led adjustments to enhance resuscitation success. The expansion of healthcare access in emerging economies, along with increasing government efforts aimed at enhancing emergency medical services, provides untapped potential for market expansion. In addition, collaborations among providers, manufacturers, and regulators have the potential to stimulate innovation, reduce costs, and enhance accessibility, which will result in wider use of these devices across multiple regions and types of healthcare facilities.

AUTOMATED CPR DEVICES MARKET REPORT COVERAGE:

Automated CPR Devices Market Segmentation:

Automated CPR Devices Market Segmentation: By Product Type

• Load-distributing band (LDB) devices
• Piston CPR devices
• Active compression-decompression (ACD) devices
• Impedance threshold devices (ITD)

LDB devices utilize an inflatable band that assists in providing even compressions, and they are very portable and user-friendly. The devices are increasing in demand as they are cheaper than other technologies. It has about 20% to 25% of the global market share since they are cheaper and more appropriate for EMS use.

Piston devices utilize a mechanical piston that compresses the chest, delivering predictable pressure and depth. Piston devices are the preferred choice for their reliability and accuracy, particularly utilized in hospitals and ambulances. Approximately 30% to 35% of the market is shared by them as they are a popular choice for advanced cardiac life support.

ACD devices both compress and decompress the chest with the goal of increasing cardiac output during CPR. With their capacity to achieve improved circulation during resuscitation, they are favoured in critical care units. Approximated at 25% to 30% in market share, especially in sophisticated resuscitation units.

ITDs function by generating a vacuum upon chest decompression to enhance blood flow and increase survival rates. They are generally employed as adjuncts to enhance the quality of CPR. Approximately 5% to 10% of the market is shared by them, as they tend to be used alongside other CPR devices in certain environments.

Automated CPR Devices Market Segmentation: By Compressor Type

• Automatic mechanical CPR
• Manual CPR

Fully automated, standardized chest compressions with minimal room for human error or fatigue, especially valuable in severe emergency conditions. About 50% to 55% of the market is shared by them since their efficacy and standardization make them the first preference in EMS and hospital environments.

Manual CPR, while still popular, is not as effective as mechanical devices since it is vulnerable to human fault and fatigue conditions. Nevertheless, it is indispensable in regions lacking automated devices. Approximately 45% to 50% of the market is occupied by these devices, even though manual practice is being phased out by more automated devices across most areas.

Automated CPR Devices Market Segmentation: by Application

• Hospitals
• including emergency departments and ICUs
• Ambulatory surgical centres
• Ambulances and air ambulances
• Specialty clinics
• Independent catheterisation labs
• Long-term care centres

Hospitals, particularly emergency departments and ICUs, are the biggest application segment since automated CPR machines play a key role in treating cardiac arrest patients. About 35%  to 40% of the market is shared, spurred by enormous demand for lifesaving medical treatments.

They employ CPR devices to treat possible cardiac events during operations. Although their usage is limited in comparison to hospitals, it's still a vital application for patient protection. Market share is approximately 10% to 15% of the demand is increasing for emergency equipment in operating rooms.

Automated CPR devices have become a standard in ambulances and air ambulances for uniform chest compressions during the transport of the patient. Around 20% to 25% of the market is captured since their take-up in emergency transport environments keeps increasing.

Cardiology and emergency care clinics are increasingly using automated CPR devices in cardiac emergencies. Market Share is projected at 5% to 10% due to growing awareness of successful resuscitation techniques.

Applied in catheterization labs for the management of cardiac emergencies in invasive procedures, CPR devices share approximately 5%, since they are specialized facilities where specific life-saving interventions are needed.

Long-term care centres utilize CPR equipment to manage cardiac events in their older residents. Market Share is projected at 10% to 15% since an ageing population drives the demand for emergency readiness in long-term care facilities.

Automated CPR Devices Market Segmentation: Regional Analysis:

• North America
• Asia-Pacific
• Europe
• South America
• Middle East and Africa

North America holds the largest share of the market, approximately 40% to 45%, driven by advanced healthcare infrastructure, high awareness levels, and significant investments in medical technologies, particularly in the United States. The region benefits from the widespread adoption of advanced resuscitation technologies in hospitals, ambulances, and emergency medical services (EMS).

Asia-Pacific (APAC), with an estimated market share of 20% to 25%, is experiencing rapid growth due to the increasing prevalence of cardiovascular diseases, expanding healthcare infrastructure, and rising awareness in countries like China, India, and Japan. The region’s large population and improving healthcare access, especially in urban areas, are key drivers for the market.

Europe holds 25% to 30% of the market, with countries like Germany, the UK, and France leading the adoption of automated CPR devices in emergency departments, ambulances, and ICUs. Stringent healthcare regulations, a focus on improving CPR protocols, and high investments in healthcare innovation further boost the market in Europe.

South America, while a smaller market at 5% to 10%, is growing steadily, particularly in Brazil, due to increasing cardiovascular disease rates and expanding healthcare infrastructure. The region’s improving healthcare access and rising awareness of the importance of effective CPR in emergencies are fueling market growth.

Finally, the Middle East and Africa (MEA), with an estimated market share of 5% to 7%, is seeing gradual growth, driven by healthcare modernization and rising cardiovascular diseases. Countries like Saudi Arabia, UAE, and South Africa are adopting advanced resuscitation technologies due to increasing investments in healthcare systems and growing awareness of the benefits of automated CPR devices.

COVID-19 Impact Analysis on the Global Automated CPR Devices Market:

The COVID-19 pandemic influenced the market for automated CPR devices enormously, mostly by emphasizing the demand for efficient and uninterrupted resuscitation methods in overburdened healthcare facilities. The sudden increase in cases of cardiac arrest, especially in COVID-19 patients, drove the implementation of automated CPR devices at a fast pace since the devices eliminated exposure risks for healthcare professionals and provided uninterrupted, high-quality chest compressions. The higher demand for life-saving devices during the pandemic increased awareness and the sense of urgency to improve emergency response capacity, which boosted the market. Supply chain disruptions and postponed regulatory clearances during the pandemic also challenged market growth. Long-term adoption trends were driven by the need for advanced resuscitation technologies despite these challenges.

Latest Trends/ Developments:

Recent trends in the automated CPR devices market point toward tremendous progress in technology, regulatory reforms, and wider acceptance in different healthcare environments. The incorporation of Artificial Intelligence (AI) and Machine Learning (ML) into automated CPR devices is improving their functionality, enabling real-time adjustments of compression depth and rate, and bettering patient outcomes in cardiac arrest. LUCAS 3 and AutoPulse, two topmost devices sold in the industry, have received much attention through their capacity for uniform chest compressions, markedly raising survival ratios. The market has also experienced more investments as well as studies aimed at getting the devices lower and more pocket-friendly, increasing access to such products in emerging economies as well as developed markets. Regulatory bodies like the FDA and the European Medicines Agency (EMA) have further evolved guidelines for automated CPR device approvals, enhancing safety standards and promoting innovation. In 2024, one can see a trend toward increased adoption in ambulance services and long-term care centers, where the devices are increasingly becoming a standard feature of emergency care procedures.

Key Players:

1. Zoll Medical Corporation
2. Physio-Control (Stryker Corporation)
3. Medtronic
4. Stryker Corporation
5. Laerdal Medical
6. GE Healthcare
7. Defibtech
8. Tokyo Electric Power Company (TEPCO)
9. Ambu A/S
10. Shenzhen Mindray Bio-Medical Electronics